We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.75B
AUM Growth
-$39.4M
(-0.68%)
Cap. Flow
-$856M
Cap. Flow
% of AUM
-14.88%
Top 10 Holdings %
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
1.6
quarters
Top 20 Avg Time Held Equity + Options
1.5
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
1.6
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
+$125M |
| 2 |
CVD
COVANCE INC.
CVD
|
+$75.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$71.6M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$69.7M |
| 5 |
PepsiCo
PEP
|
+$52.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$72.3M |
| 2 |
NCR Voyix
VYX
|
+$64.1M |
| 3 |
Humana
HUM
|
+$64M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$63.4M |
| 5 |
TSMC
TSM
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.33% |
| 2 | Consumer Discretionary | 12.63% |
| 3 | Healthcare | 11.94% |
| 4 | Industrials | 11.3% |
| 5 | Consumer Staples | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
CarMax
KMX
$7.47B
| – | – |
-183,647
| Closed | -$8.53M | – |
|
627
PUT
Kohl's
KSS
$2.31B
| – | – |
-100,000
| Closed | -$25K | – |
|
628
Louisiana-Pacific
LPX
$4.59B
| – | – |
-447,993
| Closed | -$6.09M | – |
|
629
Lattice Semiconductor
LSCC
$17.9B
| – | – |
-11,146
| Closed | -$84K | – |
|
630
LTC Properties
LTC
$2.29B
| – | – |
-5,774
| Closed | -$213K | – |
|
631
CALL
lululemon athletica
LULU
$10.9B
| – | – |
-103,500
| Closed | -$45K | – |
|
|
632
lululemon athletica
LULU
$10.9B
| – | – |
-26,285
| Closed | -$1.1M | – |
|
633
Lumen Technologies, Inc. Common Stock
LUMN
$5.45B
| – | – |
-45,916
| Closed | -$1.88M | – |
|
634
Matsons
MATX
$6.75B
| – | – |
-143,000
| Closed | -$3.58M | – |
|
635
McDonald's
MCD
$166B
| – | – |
-2,266
| Closed | -$215K | – |
|
636
CALL
Mondelez International
MDLZ
$77.1B
| – | – |
-50,000
| Closed | -$2K | – |
|
637
MetLife
MET
$62.5B
| – | – |
-253,430
| Closed | -$12.1M | – |
|
638
MidCap Financial Investment
MFIC
$698M
| – | – |
-13,237
| Closed | -$324K | – |
|
639
MGM Resorts International
MGM
$7.36B
| – | – |
-48,751
| Closed | -$1.11M | – |
|
640
ArcelorMittal
MT
$48.2B
| – | – |
-484,903
| Closed | -$15.2M | – |
|
641
Neurocrine Biosciences
NBIX
$14.5B
| – | – |
-100,000
| Closed | -$1.57M | – |
|
642
NRG Energy
NRG
$22.7B
| – | – |
-254,010
| Closed | -$7.74M | – |
|
643
Nuwellis
NUWE
$2.19M
| – | – |
0
| – | -$88K |
2013 Q2
6 quarters
|
|
644
Owens Corning
OC
$9.02B
| – | – |
-108,565
| Closed | -$3.45M | – |
|
645
Oshkosh
OSK
$7.73B
| – | – |
-265,951
| Closed | -$11.7M | – |
|
646
Petrobras
PBR
$163B
| – | – |
-35,100
| Closed | -$498K | – |
|
647
CALL
Public Service Enterprise Group
PEG
$36B
| – | – |
-50,000
| Closed | -$4K | – |
|
648
Prologis
PLD
$123B
| – | – |
-81,440
| Closed | -$3.07M | – |
|
649
Philip Morris
PM
$314B
| – | – |
-228,053
| Closed | -$19M | – |
|
650
Prothena Corp
PRTA
$454M
| – | – |
-35,000
| Closed | -$776K | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2014 Portfolio in Review
As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS O'Connor withdrew a net $856M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.
- UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
- UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
- UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
- UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
- UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
- UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
- UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.
Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.